Calidi Biotherapeutics, Inc.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Entry into a Material Definitive Agreement

Prospectus Supplement for Primary Offering

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Material Modifications to Rights of Security Holders

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Submission of Matters to a Vote of Security Holders

Additional Information for Proxy Statement/ Votes

Entry into a Material Definitive Agreement

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

No description available

Regulation FD Disclosure

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Results of Operations and Financial Condition

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Correspondence with the SEC

Correspondence with the SEC

Registration (IPO) statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Registration statement under Securities Act of 1933

Notice of Effectiveness

Correspondence with the SEC

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Letter from the SEC

Letter from the SEC

Registration (IPO) statement under Securities Act of 1933

Draft registration statement (confidential submission)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Preliminary Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Prospectus Supplement for Primary Offering

Letter from the SEC

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Correspondence with the SEC

Letter from the SEC

Definitive Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Preliminary Proxy Statement

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Annual report pursuant to Section 13 or 15(d)

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Preliminary Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

Sanders Corazon (Corsee) D.

Peoples George

Stewart Alan R.

Leftwich Scott

Jackson Andrew C.

Schoeneck James A

Poma Eric E

Fernandez Santidrian Antonio

Sanders Corazon (Corsee) D.

Camaisa Allan

Poma Eric E

Fernandez Santidrian Antonio

Jackson Andrew C.

Lincoln Alternative Strategies LLC